Gene · 4811
NID1: nidogen 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NID1: nidogen 1. Genes, record 4811. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4811
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P14543 | Nidogen-1 | 1,247 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents76
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4774304 A1 | 2026-07-15 | 39 | P14543 | Espacenet |
| JP 2026065032 A | 2026-04-14 | 72 | P14543 | Espacenet |
| JP 2026065032 A | 2026-04-14 | 127 | P14543 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2317 | P14543 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1879 | P14543 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 9368 | P14543 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 1928 | P14543 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7141 | P14543 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7141 | P14543 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1879 | P14543 | Espacenet |
1 to 10 of 76
See all 76 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,454
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NID1 papers | Newest fiscal year |
|---|---|---|---|
| P30EY025585 | NEI Center Core Grant for Vision Research | 12 | 2025 |
| R01EY013431 | Mechanisms of epithelial alterations in diabetic cornea | 12 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 8 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30ES010126 | UNC Center for Environmental Health and Susceptibility | 4 | 2025 |
| P20GM103446 | Delaware INBRE | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,454Source NIH's project files
See all 1,454 nih grantsPapers2,052
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune escape in portal vein tumor thrombus: an intravascular tumor-immune niche framework for hepatocellular carcinoma. | Front Immunol | 2026 | 42819771 | PubTator, text mining | PubMed |
| Novel Homozygous LAMC3 Frameshift Variant Associated with Confluent Leukoencephalopathy and Low-Grade Tectal Glioneuronal Tumor: Expanding the Phenotypic Spectrum with Bioinformatic Characterization. | Life (Basel) | 2026 | 42795349 | PubTator, text mining | PubMed |
| Identification of DUSP4 and NID1 as Biomarkers Related to Cation Homeostasis in Diabetic Retinopathy based on Transcriptomic Analysis | Endocr Metab Immune Disord Drug Targets | 2026 | 42786840 | PubTator, text mining | PubMed |
| NMJ-associated transcriptomic remodeling correlates with disease severity in juvenile dermatomyositis. | Inflamm Res | 2026 | 42700229 | PubTator, text mining | PubMed |
| Construction of 3D bioprinted colorectal cancer models and evaluation of their efficacy and drug sensitivity. | APL Bioeng | 2026 | 42578160 | PubTator, text mining | PubMed |
| In vitro generation of human embryonic stem cell-derived heart organoids possessing physiological ion currents. | Regen Ther | 2026 | 42395059 | PubTator, text mining | PubMed |
| [Combined analysis of epigenetic and transcriptomic data from children with Wiedemann-Steiner syndrome due to variants of KMT2A gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2026 | 42342635 | PubTator, text mining | PubMed |
| Predicting of survival in metastatic melanoma patients under anti-PD-1 monotherapy using genomic mutation and copy number variation. | Discov Oncol | 2026 | 42149258 | PubTator, text mining | PubMed |
| MeCP2 NID interaction with RNA: implications for Rett syndrome-relevant protein regulation. | Hum Mol Genet | 2026 | 42051147 | PubTator, text mining | PubMed |
| Integrating microbial bioremediation, multi-omics, and emerging technologies for polycyclic aromatic hydrocarbon (PAHs) detoxification. | J Microbiol Methods | 2026 | 42049067 | PubTator, text mining | PubMed |
1 to 10 of 2,052
See all 2,052 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4811
GET https://conductscience.org/api/genes/v1/4811/patents?page=2